Ukulungiselela "Rezalyut" (imiyalelo)

Phakathi amayeza ezininzi mihla isizukulwana esitsha kukho abo esilungiselelwe kuqheleke esibindini. Ezi ziquka ukulungiswa "Rezalyut" imiyalelo zokusetyenziswa oqinisekisa ukusebenza gepaprotektornogo elungileyo. ukusebenza kwayo therapeutic kungenxa kweempembelelo amacandelo ichiza ekukhawuleziseni inkqubo ngokutsha hepatic kwinqanaba zeselula. Eli chiza kunceda:

- nokuzinzisa inwebu iseli;

- isantya lipid igcwala;

- inhibition kweenkqubo njini collagen esivulekayo esibindini.

"Rezalyut" imiyalelo Drug zokusetyenziswa leyo ibonisa impembelelo ichiza phezu kuqheleke ukutya lipid ngokwehlisa amanqanaba cholesterol, iyakwazi ukukunyanzela oluntsonkothileyo inyathelo esibindini. Le Exchange nganye ezinga malungu abantu ngenxa yokuba phantsi kwempembelelo yeekhomponenti ichiza ancedisana hepatic kumanqanaba wesiseko acid linoleic kunye Ester cholesterol.

Ukulungiselela "Rezalyut" - iyeza eyenziwa kunencindi phospholipids zesoya kunye nezinye izinto amayeza, eziquka phosphatidylcholine kunye phosphoglycerides (malunga nama-76%), kunye namanqatha acid (ezona ziphambili - linoleic). Le medicament ilungiselelwe yolawulo ngomlomo. Izikali Form: gelatin, enemibala, ngaphaya njengezingxobo ulwelo viscous yegolide yellow okanye elityheli brown. Enye philisi iqulethe 600 mg lipoid ppl, eliquka phospholipids (300 mg), glycerol (120 mg), nyulu ioli zesoya (139mg), triglycerides (41 mg), kunye tocopherol (1 mg). Ukuba akukho ezinye iingcebiso igqirha okunyangayo, uthathe amayeza phambi kokuba izidlo 3 p. ngosuku 2 njengezingxobo. Njengezingxobo ingawutyisi, wabahlamba phantsi isixa esikhulu ulwelo. Ikhosi unyango kuxhomekeke kubunzima kwesi sifo.

Njengoko oogqirha ngokuya ukumisela ichiza "Rezalyut" mva nje. ngesicelo imiyalelo eboniswe bungqina:

- kohlobo, yamehlo okunamafutha kwesibindi inyama of etiologies ezahlukahlukeneyo;

- izilonda ubuthi;

- isibindi kwesibindi, hypercholesterolemia (kuthelekiswa kakuhle kunye nokongezwa zokutya ukulungiselela ukuncitshiswa weight).

Izimo - syndrome antiphospholipid, hypersensitivity ukuya phospholipids (iimbotyi zesoya, namandongomane). Ngenyameko kuyimfuneko ukuthatha amachiza kubantwana abangaphantsi kweminyaka 12.

Ukuza kuthi ga ngoku, akukho ukunxila okanye libanda, imithi ongaziwayo. zimpawu beziyobisi kwakhona ayifakwanga kunye namanye amayeza. Nangona wathengisa ngaphandle kagqirha, phambi kokuba uqale unyango kufuneka adibane ingcaphephe malunga ukwamkelwa ngaxeshanye iziyobisi ezahlukeneyo (ingakumbi ukuba ezinye zazo anticoagulants coumarin).

Ulwazi malunga nokusetyenziswa ekhuselekileyo kweli chiza ngexa lokukhulelwa kunye lokwaphusa azifumaneki, ngoko ke kweli xesha kuphela xa kagqirha, inzuzo ezilindelekileyo mkhulu umngcipheko waqonda olungekazalwa. Xa ufumana ebudeni zisanyisa lokuncancisa iyeka ngokupheleleyo.

Drug "Rezalyut" umyalelo leyo eyalatha inani elincinane ziziphumo ebezingalindelekanga, ichiza zisenako entsha ezishelfini abantu ezikhemisti, ngoko awunaku kwazi engalawulekiyo ndibuthabathe. Phambi kokungeniswa kufuneka udibane nogqirha.

ziphumo bezingalindelekanga kunokwenzeka - urhudo, iintlungu esiswini, irhashalala, kunqabile - amaqhakuvana petechial, zesibeleko ukopha phakathi kwamathuba sexesheni. Amaninzi, ezi mpawu kwenzeka xa uthatha i idosi iphezulu ichiza ixesha elide. Not ngaphandle isici yeekhomponenti zeziyobisi. Ukuba ngaba uneziphumo ebezingalindelekanga uyeka ezithatha ichiza bafune unyango.

Ukulungiselela "Rezalyut" igcinwe kwiqondo lobushushu ukuya ku-25 ° C kwiminyaka ukuya ku-2.